1. Zhang S, Wei X, Zhang H, Wu Y, Jing J, Huang R, et al. Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway. Biomed Pharmacother. 2023;162:114691.
2. Tayal U, Ware JS, Lakdawala NK, Heymans S, Prasad SK. Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. Europ Heart J. 2021;42(24):2384-96.
3. Shi H, Yuan M, Cai J, Lan L, Wang Y, Wang W, et al. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy. J Trans Med. 2024;22(1):297.
4. Biwott FK, Rao N-N, Dong C-L, Wang G-B. Weighted gene co-expression network analysis reveals similarities and differences of molecular features between dilated and ischemic cardiomyopathies. J Electronic Sci Technol. 2023;21(2):100193.
5. Heymans S, Lakdawala NK, Tschöpe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet (London, England). 2023;402(10406):998-1011.
6. Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci. 2021;22(14).
7. Guan Z, Chen J, Wang L, Hao M, Dong X, Luo T, et al. Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy. Phytomedicine. 2023;108:154494.
8. López B, Ravassa S, Moreno MU, José GS, Beaumont J, González A, et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;18(7):479-98.
9. Chen X, Zhang F, Hu G, Li X, Wang L, Li C, et al. LRRC8A critically regulates myofibroblast phenotypes and fibrotic remodeling following myocardial infarction. Theranostics. 2022;12(13):5824-35.
10. Bacmeister L, Schwarzl M, Warnke S, Stoffers B, Blankenberg S, Westermann D, et al. Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol. 2019;114(3):19.
11. Rubis P, Dziewiecka E, Wisniowska-Smialek S, Banys P, Urbanczyk-Zawadzka M, Krupinski M, et al. Natural history of myocardial fibrosis in dilated cardiomyopathy. Europ Heart J. 2022;43(Supplement_2).
12. Barcena ML, Pozdniakova S, Haritonow N, Breiter P, Kühl AA, Milting H, et al. Dilated cardiomyopathy impairs mitochondrial biogenesis and promotes inflammation in an age- and sex-dependent manner. Aging. 2020;12(23):24117-33.
13. Wang E, Zhou R, Li T, Hua Y, Zhou K, Li Y, et al. The Molecular Role of Immune Cells in Dilated Cardiomyopathy. Medicina (Kaunas, Lithuania). 2023;59(7).
14. Gao RF, Li X, Xiang HY, Yang H, Lv CY, Sun XL, et al. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction-induced myocardial fibrosis and cardiac remodeling in mice. Int Immunopharmacol. 2021;90:107133.
15. Peng Y, Qin D, Wang Y, Gao W, Xu X. Pharmacological inhibition of ICOS attenuates the protective effect of exercise on cardiac fibrosis induced by isoproterenol. Europ J Pharmacol. 2024;965:176327.
16. Du S, Li Z, Xie X, Xu C, Shen X, Wang N, et al. IL-17 stimulates the expression of CCL2 in cardiac myocytes via Act1/TRAF6/p38MAPK-dependent AP-1 activation. Scand J Immunol. 2020;91(1):e12840.
17. Crawford MP, Sinha S, Renavikar PS, Borcherding N, Karandikar NJ. CD4 T cell-intrinsic role for the T helper 17 signature cytokine IL-17: Effector resistance to immune suppression. Proc Natl Acad Sci U S A. 2020;117(32):19408-14.
18. Li X, Bechara R, Zhao J, McGeachy MJ, Gaffen SL. IL-17 receptor-based signaling and implications for disease. Nat Immunol. 2019;20(12):1594-602.
19. Chen L, Wei XQ, Evans B, Jiang W, Aeschlimann D. IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Europ J Immunol. 2008;38(10):2845-54.
20. Tomczyk MM, Cheung KG, Xiang B, Tamanna N, Fonseca Teixeira AL, Agarwal P, et al. Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress. Circul Heart failure. 2022;15(5):e008547.
21. Liu Z, Liu X, Liu L, Wang Y, Zheng J, Li L, et al. SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity. J Pharmaceutical Analysis. 2023;13(2):170-86.
22. Chen QQ, Ma G, Liu JF, Cai YY, Zhang JY, Wei TT, et al. Neuraminidase 1 is a driver of experimental cardiac hypertrophy. Europ Heart J. 2021;42(36):3770-82.
23. Cui Y, Li J, Zhang P, Yin D, Wang Z, Dai J, et al. B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. J Exp Cin Cancer Res. 2023;42(1):146.
24. Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. Pathol Int. 2020;70(1):1-11.
25. Mathew T, Williams L, Navaratnam G, Rana B, Wheeler R, Collins K, et al. Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Echo Res Practice. 2017;4(2):G1-g13.
26. Wong NR, Mohan J, Kopecky BJ, Guo S, Du L, Leid J, et al. Resident cardiac macrophages mediate adaptive myocardial remodeling. Immunity. 2021;54(9):2072-88.e7.
27. Liu M, López de Juan Abad B, Cheng K. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Delivery Rev. 2021;173:504-19.
28. Frangogiannis NG. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med. 2019;65:70-99.
29. Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells. 2020;9(5).
30. Tang Y, Si Y, Liu C, Li C, Qu L, Liu Y, et al. hUMSCs Restore Uterine Function by Inhibiting Endometrial Fibrosis via Regulation of the MMP-9/TIMP-1 Ratio in CDDP-Induced Injury Rats. Stem cells Int. 2023;2023:8014052.
31. Yang F, Luo L, Zhu ZD, Zhou X, Wang Y, Xue J, et al. Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo. Fronti Pharmacol. 2017;8:929.
32. Wang SQ, Li D, Yuan Y. Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway. J Physiological Sci. 2019;69(6):861-73.
33. Jiang Y, Chai L, Wang H, Shen X, Fasae MB, Jiao J, et al. HIV Tat Protein Induces Myocardial Fibrosis Through TGF-β1-CTGF Signaling Cascade: A Potential Mechanism of HIV Infection-Related Cardiac Manifestations. Cardiovascular Toxicol. 2021;21(12):965-72.
34. Maisch B, Pankuweit S. Inflammatory dilated cardiomyopathy: Etiology and clinical management. Herz. 2020;45(3):221-9.
35. Harding D, Chong MHA, Lahoti N, Bigogno CM, Prema R, Mohiddin SA, et al. Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy. J Int Med. 2023;293(1):23-47.
36. Wang J, Han B. Dysregulated CD4+ T Cells and microRNAs in Myocarditis. Front Immunol. 2020;11:539.
37. Lu Y, Zhao N, Wu Y, Yang S, Wu Q, Dong Q, et al. Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4+ T cell metabolism. Cardiovascular Res. 2023;119(6):1377-89.
38. Mohr A, Malhotra R, Mayer G, Gorochov G, Miyara M. Human FOXP3(+) T regulatory cell heterogeneity. Clin Transl Immunology. 2018;7(1):e1005.
39. Ilatovskaya DV, Halade GV, DeLeon-Pennell KY. Adaptive immunity-driven inflammation and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2019;317(6):H1254-h7.